Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 11/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.48 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.48 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18624987 | 1.00 | CYP2A6 (0.64) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17060239 | 1.00 | CYP2A6 (0.64) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL18624986 | 0.91 | CYP2A6 (0.56) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL18624988 | 0.89 | CYP2A6 (0.55) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17060220 | 0.87 | CYP2A6 (0.57) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17080409 | 0.86 | PTGS2 (0.50) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17060233 | 0.84 | SLC2A1 (0.53) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17060302 | 0.83 | CYP2A6 (0.46) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL29695665 | 0.83 | CYP2A6 (0.46) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB | |
| SCHEMBL17060301 | 0.83 | CYP2A6 (0.46) | CYP2A6CYP3A4ALDH1A1CYP1A2PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307410-B2 | Mcl-1 modulating compounds for cancer treatment | CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE (FR) | 2019-06-04 | — | — | US | disclosed |
| US-20170071921-A1 | MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT | CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE (FR) | 2017-03-16 | — | — | US | disclosed |
| US-20170071921-A1 | MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT | CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE (FR) | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170071921-A1 | MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT | MCL1, BCL2A1, BCL2L1 | CYP2A6 3028/4885CYP3A4 3877/4885ALDH1A1 530/4885 |
| US-10307410-B2 | Mcl-1 modulating compounds for cancer treatment | MCL1, BCL2A1, BCL2L1 | CYP2A6 3028/4885CYP3A4 3877/4885ALDH1A1 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.